Activation of cyclin D1 expression by the ERK5 cascade

Autor: Alexandre Philips, Roseann Mulloy, Sara Salinas, Robert A. Hipskind
Přispěvatelé: Institut de Génétique Moléculaire de Montpellier (IGMM), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)
Rok vydání: 2003
Předmět:
Cancer Research
Cyclin E
Transcription
Genetic

Cyclin D
Cyclin A
Cyclin B
Breast Neoplasms
Genetic Tumor Cells
03 medical and health sciences
0302 clinical medicine
Cyclin D1
Cyclin-dependent kinase
Genetics
Tumor Cells
Cultured

Humans
[SDV.BBM]Life Sciences [q-bio]/Biochemistry
Molecular Biology

Promoter Regions
Genetic

Molecular Biology
Mitogen-Activated Protein Kinase 7
030304 developmental biology
Mitogen-Activated Protein Kinase 1
0303 health sciences
Cultured
Mitogen-Activated Protein Kinase 3
biology
Gene Expression Regulation
Neoplastic

Kinetics
030220 oncology & carcinogenesis
biology.protein
Cancer research
Cyclin-dependent kinase complex
Female
Neoplastic/*physiology Humans Kinetics Mitogen-Activated Protein Kinase 1/metabolism Mitogen-Activated Protein Kinase 3 Mitogen-Activated Protein Kinase 7 Mitogen-Activated Protein Kinases/*metabolism Promoter Regions (Genetics) Transcription
Mitogen-Activated Protein Kinases
Breast Neoplasms Cyclin D1/biosynthesis/*genetics Female Gene Expression Regulation
Cyclin A2
Zdroj: Oncogene
Oncogene, Nature Publishing Group, 2003, 22 (35), pp.5387--98. ⟨10.1038/sj.onc.1206839⟩
ISSN: 0950-9232
1476-5594
DOI: 10.1038/sj.onc.1206839⟩
Popis: Transcriptional activation of the cyclin D1 gene is a key step in cell proliferation. Accordingly, cyclin D1 overexpression is frequently an early step in neoplastic transformation, particularly in mammary epithelium. Numerous studies have linked elevated cyclin D1 promoter activity to a sustained activation of the ERK1/2 cascade. Here we show that the ERK5 cascade, a distinct mitogen-induced MAPK pathway, can also drive cyclin D1 expression. In CCL39 cells, serum induces a strong, prolonged peak of ERK1/2 and ERK5 phosphorylation, and subsequently elevates cyclin D1 mRNA and protein levels. Overexpression of constitutively active MEK5 and wt ERK5 induces a cyclin D1 reporter gene (D1 -973-luciferase) at least as well as constitutively active MEK1. Activation is blocked by kinase-dead mutants of ERK5 and ERK2, respectively. Mutation of the CRE at -50 in the cyclin D1 promoter decreases activation by the ERK5 but not the ERK1/2 cascade. Importantly, expression of kinase-dead ERK5 diminishes endogenous cyclin D1 protein induction by serum in CCL39 cells and the breast cancer cell lines MCF-7 and HS579. These data identify the cyclin D1 gene as a novel target of the ERK5 cascade, an observation with important implications in cancers involving cyclin D1 deregulation.
Databáze: OpenAIRE